4.7 Article

Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15

期刊

EUROPEAN JOURNAL OF NEUROLOGY
卷 19, 期 7, 页码 955-962

出版社

WILEY
DOI: 10.1111/j.1468-1331.2011.03650.x

关键词

25-hydroxyvitamin D; case-control studies; multiple sclerosis; sunlight

资金

  1. Biogen Idec
  2. Sanofi-aventis
  3. Bayer-Schering Pharma and Diasorin AB
  4. AFA Foundation
  5. Soderbergs Foundation
  6. Swedish Association for Persons with Neurological Disabilities
  7. Swedish Research Council
  8. Swedish Council for Working life and Social Research
  9. Bayer-Schering
  10. Merck-Serono
  11. Teva
  12. Bayer
  13. Merck
  14. EU
  15. Neuropromise
  16. Euratools
  17. Bibbi and Niels Jensens foundation
  18. Swedish Medical Research Council

向作者/读者索取更多资源

Background: Both insufficient exposure to sunlight and vitamin D deficiency have been associated with an increased risk for multiple sclerosis (MS). An interaction between human leukocyte antigen HLA-DRB1*15 and vitamin D in MS was recently proposed. We investigated the association between previous exposure to ultraviolet radiation (UVR), vitamin D status at inclusion in the study, and MS risk including the interaction of these factors with HLA-DRB1*15. Methods: A population-based casecontrol study involving 1013 incident cases of MS and 1194 controls was performed in Sweden during 20052010. Subjects were classified according to their UVR exposure habits, vitamin D status, and HLA genotypes. The associations between different sun exposure habits/vitamin D levels and MS were calculated as odds ratios (OR) with 95% confidence intervals (CI) using logistic regression. Potential interaction was evaluated by calculating the attributable proportion due to interaction. Results: Subjects with low UVR exposure had a significantly increased risk of MS compared with those who reported the highest exposure (OR 2.2, 95% CI 1.53.3). Similarly, subjects who had 25-hydroxy-vitamin D levels less than 50 nM/l had an increased risk for MS (OR 1.4, 95% CI 1.21.7). The association between UVR exposure and MS risk persisted after adjustment for vitamin D status. There was no interaction with HLA-DRB1*15 carriage. Conclusions: UVR and vitamin D seem to affect MS risk in adults independently of HLA-DRB1*15 status. UVR exposure may also exert a protective effect against developing MS via other pathways than those involving vitamin D.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据